22.09.2022 • News

Consortium Plans Carbon Capture in Singapore

Air Liquide, Chevron, PetroChina and Keppel Infrastructure are planning to form a consortium that will explore the development of large-scale carbon capture, utilization and sequestration (CCUS) solutions and integrated infrastructure in Singapore.

Under a Memorandum of Understanding announced on Sep. 21, the consortium intends to research, test and develop technological, logistical and operational solutions for CCUS on the island.

As such, the partners will look to provide industry-wide CCUS integrated infrastructure, primarily to support the energy and chemicals sector, by capturing and aggregating CO2 from large industrial emitters at a centralized collection facility.

Singapore has three major refineries – ExxonMobil at Pulau Ayer Chawan, Shell on Pulau Bukom and Singapore Refining on Pulau Merlimau – as well several petrochemical plants operated by some of the world’s leading producers that include Chevron, Shell and ExxonMobil.

© pressmaster/Shutterstock
© pressmaster/Shutterstock

The captured CO2 could be used to make plastics, fuels and cement, or transported via pipelines or ships to suitable reservoirs in the Asia-Pacific region for sequestration by injecting the gas in deep underground geologic formations for permanent storage.

Michele Gritti, vice president, large industries and energy transition at Air Liquide in Southeast Asia, said supporting industry decarbonization to help address the urgency of climate change was a priority.

Author: Elaine Burridge, Freelance Journalist

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read